Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept
Download31 - 36 of 232 results
Placebo-controlled First-in-Human Study of Oral TQS-168 in Healthy Volunteers
17 December 2024In Vitro and Clinical Evaluations of UGT1A1-, P-gp-, OATP1B1-, and BCRP-Mediated Drug–Drug Interactions of Belumosudil, a Potent ROCK2 Inhibitor
17 December 2024On-Demand: Leveraging Real-Time Clinical Data to Deliver Certainty in Solubility Enhancement and Modified Release Development
12 December 2024Quotient Sciences 2023 ESG Report
10 December 2024Modelling and Simulation of the Effect of a Permeability Enhancer on the Absorption of a Poorly Permeable Compound
6 November 2024Quotient Sciences Predicting Belumosudil Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model
6 November 2024Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.